- Home
- PCLA vs ANTX Comparison
PCLA vs ANTX Comparison
Compare PCLA & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCLA
- ANTX
- Stock Information
- Founded
- PCLA 2008
- ANTX 2017
- Country
- PCLA Japan
- ANTX United States
- Employees
- PCLA N/A
- ANTX N/A
- Industry
- PCLA Building Products
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- PCLA Consumer Discretionary
- ANTX Health Care
- Exchange
- PCLA Nasdaq
- ANTX Nasdaq
- Market Cap
- PCLA 71.3M
- ANTX 33.2M
- IPO Year
- PCLA 2025
- ANTX 2022
- Fundamental
- Price
- PCLA $0.91
- ANTX $1.10
- Analyst Decision
- PCLA
- ANTX Buy
- Analyst Count
- PCLA 0
- ANTX 2
- Target Price
- PCLA N/A
- ANTX $2.00
- AVG Volume (30 Days)
- PCLA 3.7M
- ANTX 95.4K
- Earning Date
- PCLA 01-01-0001
- ANTX 08-12-2025
- Dividend Yield
- PCLA N/A
- ANTX N/A
- EPS Growth
- PCLA N/A
- ANTX N/A
- EPS
- PCLA N/A
- ANTX N/A
- Revenue
- PCLA $5,475,228.00
- ANTX N/A
- Revenue This Year
- PCLA N/A
- ANTX N/A
- Revenue Next Year
- PCLA N/A
- ANTX N/A
- P/E Ratio
- PCLA N/A
- ANTX N/A
- Revenue Growth
- PCLA 40.19
- ANTX N/A
- 52 Week Low
- PCLA $0.37
- ANTX $0.87
- 52 Week High
- PCLA $9.80
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- PCLA N/A
- ANTX 48.42
- Support Level
- PCLA N/A
- ANTX $1.05
- Resistance Level
- PCLA N/A
- ANTX $1.10
- Average True Range (ATR)
- PCLA 0.00
- ANTX 0.04
- MACD
- PCLA 0.00
- ANTX 0.00
- Stochastic Oscillator
- PCLA 0.00
- ANTX 50.00
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.